PS27 registrations are now live! Register at psychedelicscience.org →
Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Community Allies
  • Our Work
    • Advancing Research
    • Changing Policy
    • Evolving Education
    • Psychedelic Science 2027
  • Resources
    • MAPS Bulletin
    • Psychedelic Integration
    • Policy Guidebook
    • Music Is the Bridge
    • The Virtual Trip
    • Community Events
  • News
    • Updates
    • Announcements
    • MAPS in the Media
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Volunteer
    • Careers
  • Store
    • The Dose (New Items)
    • Learning
    • Apparel
    • Accessories
    • Bookshop
Login
  • Donate
0

Phase 3 Trials: MDMA-Assisted Therapy for PTSD

Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Study Site Opens for Phone Screening in Tel Hashomer, Israel

On February 3, our Phase 3 study site for MDMA-assisted psychotherapy for PTSD in Tel Hashomer, Israel, officially opened for phone screenings and informed consent visits. Led by Principal Investigator …
February 3, 2022

MDMA-Assisted Therapy for PTSD: An Update on the Progress of MAPS’ Pivotal Program

Our second Phase 3 clinical trial of MDMA-assisted therapy for PTSD is well underway, with enrollment of more than two-thirds of the participants needed to complete the study. We have also begun our long …
December 21, 2021

TODAY Show: New Research Shows How Psychedelic Drug Can Help People With PTSD

MAPS is on The TODAY Show! This morning, NBC educated millions of people about psychedelic science by airing an interview with MAPS Founder Rick Doblin, Ph.D., and MDMA-assisted therapy study participants …
November 5, 2021

Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers

We are currently seeking research volunteers for our second Phase 3 clinical trial of MDMA-assisted therapy for PTSD. Volunteers must have PTSD and live in an area close to a study site. People of color …
October 20, 2021

Matters Arising: MAPS’ Pivotal Phase 3 Trial Advances Scientific Discourse in Nature Medicine

The results of the first Phase 3 clinical trial of MDMA-assisted therapy for PTSD have sparked scientific discourse: Highly statistically significant results and exceptional outcomes for people living …
October 14, 2021

Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers

We are currently seeking research volunteers for our second Phase 3 clinical trial of MDMA-assisted therapy for PTSD. Volunteers must have PTSD and live in an area close to a study site. Volunteers will …
September 11, 2021

Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers

We are currently seeking research volunteers for our second Phase 3 clinical trial of MDMA-assisted therapy for PTSD. Volunteers must have PTSD and live in an area close to a study site. Volunteers will …
August 16, 2021

Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers

We are currently seeking research volunteers for our second Phase 3 clinical trial of MDMA-assisted therapy for PTSD. Volunteers will help contribute to scientific knowledge and will help us better understand …
July 26, 2021

First Participant in Israel Enrolled in Phase 3 MDMA-Assisted Therapy Study in Israel

On June 11, 2021, the first participant in Be’er Ya’akov (Merhavim), Israel, was enrolled in our randomized, double-blind, placebo-controlled, multi-site Phase 3 study of the efficacy and safety of …
June 11, 2021

Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers

We are currently seeking research volunteers for our second Phase 3 clinical trial of MDMA-assisted therapy for PTSD. Volunteers will help contribute to scientific knowledge and will help us better understand …
June 11, 2021

Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Publication in Nature Medicine and Major Media Coverage

On May 3, 2021, we announced that the first Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder (PTSD) which replicated and expanded on Phase 2 results indicates that MDMA-assisted …
May 21, 2021

Phase 3 Trials of MDMA-Assisted Therapy for PTSD May 2021 Update: Seeking Research Volunteers

We are currently seeking research volunteers for our second Phase 3 clinical trial of MDMA-assisted therapy for PTSD. Volunteers will help contribute to scientific knowledge and will help us better understand …
May 21, 2021

Posts pagination

Newer Posts Page 1 Page 2 … Page 5 Older Posts
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
    • Global Affiliates
  • Our Work
    • Psychedelic Fundamentals
    • The Virtual Trip
    • U.S. MDMA Therapy Education
    • Health Equity
    • Policy & Advocacy
  • Advancing Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit
© 1986 - 2026 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mail checks to: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.
Designed with WordPress. Hosted by Pressable.

Download our Integration Guide

Just enter your email in order to download our Integration Guide